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Abstract: Bacillus thuringiensis (Bt) is the most successful, environmentally-friendly, and intensively
studied microbial insecticide. The major characteristic of Bt is the production of proteinaceous crystals
containing toxins with specific activity against many pests including dipteran, lepidopteran, and
coleopteran insects, as well as nematodes, protozoa, flukes, and mites. These crystals allow large
quantities of the protein toxins to remain stable in the environment until ingested by a susceptible
host. It has been previously established that 135 kDa Cry proteins have a crystallization domain at
their C-terminal end. In the absence of this domain, Cry proteins often need helper proteins or other
factors for crystallization. In this review, we classify the Cry proteins based on their requirements
for crystallization.
Keywords: Bacillus thuringiensis; C terminal domain; helper protein
1. Introduction
Bacillus thuringiensis (Bt) is a gram-positive, spore-forming bacterium which forms large
parasporal crystals during sporulation. These Cry toxin containing crystals have insecticidal activity
against many insect orders such as Coleoptera, Lepidoptera, and Diptera, and also against some
nematodes, protozoa, andmites [1]. Bt based biopesticides are environmentally-friendly and are widely
used for the control of forest and agricultural pests, as well as of vectors of human disease [1,2]. These
toxins have also been used as alternatives or supplements to synthetic chemical pesticides [3]. To date
more than 700 cry genes belonging to 74 classes have been described (http://www.lifesci.sussex.ac.
uk/home/Neil_Crickmore/Bt/intro.html)
The high level of Cry protein synthesis is regulated at many levels, including transcriptional,
posttranscriptional, and posttranslational, and includes effective promoter function, stable mRNA,
co-expression, and assistance by accessory proteins [4–8]. Cry protein synthesis is driven by strong
sporulation dependent promoters [4]. The production and accumulation of Cry proteins in the form of
crystals during sporulation may help protect the protein from degradation by the proteolytic enzymes
that are produced during stationary phase [9].
The three-domain Cry (3d-Cry) toxins are globular molecules containing three distinct domains.
Domain I is an alpha-helical N terminal domain. Domains II and III are predominantly beta-sheet in
nature. One particular feature of the members of the 3d-Cry group is the presence of protoxins with
two different lengths of ca. 65 and 135 kDa [6]. The 135 kDa Cry proteins, such as Cry1A, are protoxins
in which the actual toxin is at the N-terminus. The C-terminal half has no toxic function, yet is highly
conserved among the large set of 135 kDa toxins [10]. It helps in the crystallization of Cry toxin after
production [11]. It has been previously established that 135 kDa toxins without their C-terminal half
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are unable to crystallize within the Bt strain. This so-called crystallization domain comprises 15 to
19 cysteines and contributes to the formation of intermolecular disulfide bonds which stabilize the
crystal [12]. In the reducing environment of an insect gut, the cross-links dissociate, releasing protoxin
which then undergoes proteolysis to the mature toxin core [13]. Many of the cysteine residues are
located on flexible loops in the protoxin domain [10].
The C-terminal extension of the large Cry protoxin has been used as a peptide tag to facilitate
the crystallization of recombinant fusion proteins. Hayakawa et al. [14] used a peptide tag derived
from the C-terminal half of the Cry4Aa protoxin (amino acids 696–851) to enhance the production and
purification of functional TpN protein [14].
3d-Cry proteins of 65 kDa have no C-terminal domain and consist solely of the toxin domain.
However, most of these naturally truncated toxins still crystallize readily in Bt. In many cases, other
factors are known to be involved, including elements upstream or downstream of the cry genes termed
“crystallization” [4] or “helper” proteins [15].
Here we discuss factors affecting the crystallization of such 3d-Cry proteins. We have split our
discussion into four separate sections:
• Separate crystallization domain open reading frames (ORFs)
• Other known crystallization factors
• Toxins with putative crystallization factors
• No known crystallization factors
2. Separate Crystallization Domain ORF
Some three-domain Cry toxins have a typical 135 kDa toxin gene that is divided into two separate
ORFs. The products of the two ORFs resemble the C-terminal half and the N-terminal half of a 135 kDa
toxin. Examples of such Cry proteins are given below, grouped by their known activity.
2.1. Mosquitocidal Bt Toxins
Figure 1 shows the configuration of various mosquitocidal Bt toxin genes including cry10A [16],
cry19A [17,18], cry24B [19], cry30C [20], cry39A [21], cry40A (GenBank accession No. AB074414),
cry44A [22], and cry59A [23]. In each case, the upstream ORF encodes the toxin and the downstream
one is the crystallization domain. Barboza-Corona et al. [17] determined the functions of two proteins
by expressing different combinations of Cry19A, ORF2, and the N- or C-terminal half of Cry1C in the
acrystalliferous Bt strain 4Q7. Their results confirmed that ORF2 of Cry19A assisted in the production
and crystallization by functioning like the C-terminal domain of a 135 kDa toxin.
The length of the intergenic regions is 48 bp, 145 bp, and 114 bp in cry10A, cry19A, and cry30C,
respectively [16,18,20]. There is no homology between these regions and any known transposon
or insertion element sequence that could explain the gene separation. Given the high degree of
conservation between the ORF2 genes and the C-terminal extensions of the larger toxins, it seems
likely that one configuration evolved from the other [24]. It is suggested that the two-gene operon of
cry19A is the result of mutations that accrued in the extant separating region between cry19A and orf2.
However, factors responsible for this arrangement are still unknown. It may have evolved through the
insertion of a DNA fragment into a gene that previously encoded a 135 kDa protein [17,20].
2.2. Nematocidal Bt Toxins
Lenane et al. [25] identified a new member (cry5Ad) of the nematocidal cry5A family of Bt cry
protoxin genes. This represents another example of the split gene family described above. The genes
encoding Cry5Ad (931 aa) and ORF2-5Ad (502 aa) are organized in an operon and separated by 77 bp
in Bt strain L366 (Figure 1). Cry5Ad and Orf2-5Ad are distinct from the other members of this family
(Cry5Aa-c), which are expressed as single 135–150 kDa δ-endotoxins. It was suggested that the Cry5Ad
Toxins 2017, 9, 80 3 of 13
ORF2, as a major component of the protein crystal, accomplished all the functions ascribed to the
C-terminus of the other members of this family [25].
2.3. Parasporin Toxins
Parasporins are Bt Cry toxins that have no known insecticidal activity, but are toxic to a variety of
human cancer cell lines. Two classes of these are split 3d-Cry toxins.
2.3.1. Cry41A
The Cry41A toxins are 88 kDa in size and when treated with proteinase K release a 64 kDa protein
with cytocidal activity against HepG2 (liver hepatocyte) and human cancer cell line HL60 (myeloid
leukemia) [26]. Structurally, cry41Aa/Ab are three gene operons with three ORFs in the same orientation,
as shown in Figure 1. Sequence analysis identified ribosome binding sites associated with all orf s. ORF1
of cry41Aa encodes 180 amino acid residues (predicted M.W 19.5 kDa), but has no known role in the
expression or function of this toxin. ORF2 contains the five conserved blocks found in other insecticidal
three domain toxins and encodes an 825aa protein. At the C-terminal end of ORF2 is a 110 amino acid
conserved beta-trefoil “ricin” domain containing tandem repeats of QXW/F motif [27]. This is similar
to a HA-33 like domain present in the Clostridium botulinum type C mammalian neurotoxin that causes
botulism disease. [28]. The HA-33 component is responsible for haemagglutination and aggregation of
erythrocytes caused by the toxin complex from Clostridium botulinum.
The third gene (orf3) encodes a polypeptide with a predicted molecular weight of 82 kDa.
It possesses six to eight conserved blocks which show similarity with the C-terminus of the larger
3d-Cry toxins. Cry41Ab shows gene organization similar to Cry41Aa. Krishnan [29] investigated the
role of the ORFs and of the ricin domain in crystal and protein production by individually deleting
them from the operon. There was apparently no role of ORF1 or the ricin domain, since their deletion
did not affect protein expression. Deleting ORF3 resulted in the reduced expression of Cry41Aa/ORF2
and the formation of insoluble inclusions, indicating that ORF3 is required for proper expression [29].
2.3.2. Cry65Aa1
Another interesting example for this type of operon organization is the 118 kDa Cry65Aa1
toxin which reportedly requires two C-termini for crystallization [30]. The N-terminus of Cry65Aa1
resembles a typical three-domain Cry protein. The C-terminal domain is only 36.7 kDa in contrast to
the 55–65 kDa domain of the 135 kDa 3d-Cry toxins (Figure 1). Furthermore, there is little sequence
similarity between the Cry65Aa C-terminal domain and those of the 3d-Cry toxins. The operon
contains a downstream gene encoding an ORF which, like the examples described above, resembles
the C-terminal half of the 135 kDa 3d-Cry toxins. This downstream ORF was shown to be required
for the efficient expression and crystallization of the Cry65Aa toxin. Peng et al. [30] claimed that
the unusual C-terminus of Cry65Aa is also required for crystallization, although this was not clearly
demonstrated. Interestingly this report described how a stem-loop structure within the orf2 gene
sequence can aid expression by stabilizing the cry65Aa mRNA.
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Figure 1. Organization of operons having separate C-terminal domain open reading frames (ORFs):
(A) cry5Ad from Bacillus thuringiensis (Bt) strain L366; (B) cry10A from Bt subsp. israelensis; (C) cry19A
from Bt subsp. jegathesan; (D) cry24B from Bt subsp. sotto; (E) cry30C from Bt subsp. jegathesan;
(F) cry39A from Bt subsp. aizawai; (G) cry40A from Bt subsp. aizawai; (H) cry41A from Bt strain A146;
(I) cry44A from Bt subsp. entomocidus; (J) cry59A from Bt Bm59-2; (K) cry65Aa from Bt strain SBT-003.
3. Other Known Crystallization Factors
For a number of other Cry toxins, additional factors that are unrelated to the C-terminus of the
3d-Cry proteins have been shown to be necessary for in vivo crystallization of the toxin. These are
discussed below.
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3.1. Cry2A Toxins and the ORF2 Repeat Proteins
The genes encoding many of these toxins are also found in the form of operons [31–34]. In the case
of the cry2Aa and cry2Ac operons, the toxin genes are associated with two other upstream genes, orf1
and orf2 (Figure 2). The deletion of orf1 had no effect on the production of Cry2Aa or Cry2Ac toxins in
Bt [32,35]. In contrast, deletion of the orf2 gene from the cry2Aa operon prevented the formation of
regular sized crystals even though some toxin was still expressed [35]. It was later shown that Cry2Aa
expressed in the absence of ORF2 was distributed randomly in the sporulating cell rather than being
concentrated in the cuboidal crystal [36]. The 29 kDa ORF2 protein from the Cry2Aa operon contains
a tandem array of eleven repeats of a 15 amino acid motif [31] and it has been speculated that these
might form a framework for the crystallization of the Cry2 toxin. Repeat sequences were also identified
in the C-terminal region of various other toxins including Cry19Aa, Cry19Ba, Cry20Aa, Cry27Aa, and
Cry39/40 [24,36] although the role of these, if any, in crystallization is unknown. Although the cry2Ab
gene is found in many Bt strains, it is not expressed to any significant extent. Crickmore et al. [37]
found similarity in the 130 nucleotides upstream of the structural genes between cry2Ab and cry2Aa/Ac
and speculated that cry2Ab may once have been part of a similar operon structure. When Cry2Ab was
expressed in tandem with ORF2 from the Cry2Aa operon, crystals were then formed [37].
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Figure 2. Schematic illustration of Cry toxin operons including potential chaperone genes from Bt
subsp. kurstaki (A); Bt subsp. israelensis (B).
It has been reported that DNA fragments are an integral component of some crystals and form
protoxin-20 kb DNA complexes [38]. Such a complex might function in crystal formation during the
sporulation phase [39,40]. DNA in Cry1 crystals and ORF2 in Cry2Aa crystals could have a similar
function, as the highly acidic nature of the Orf2 repeats might mimic the charged phosphate groups on
the DNA backbone [36]. However, there is a need to investigate the nature of the association between
DNA and Cry protein, as well as the function of DNA in the generation of the protoxin and the stability
of the protein [41].
3.2. Cry11A and p20
Cry11Aa (formerly known as CryIVD, [42]) is the most active toxin found in the Bt subsp.
israelensis crystal, which is effective against a range of mosquito larvae [43]. The toxin is encoded
by a gene found in a three-gene operon comprising cry11A (72 kDa), p19, and p20 [44,45] (Figure 2).
SigE controls the transcription of cry11Aa [31]. The first ORF (p19) of the cry11A operon encodes the
p19 polypeptide, which shows significant sequence similarity with the orf1 gene of the Bt cry2Aa and
cry2Ac operons. The amino acid composition of p19 reveals about 11.7% cysteine residues, like the
C-terminal halves of the 135 kDa endotoxins. Dervyn et al. [45] suggest that it might be acting as a
chaperone protein and via protein-protein interactions confer a particular lattice structure to allow the
co-assembly of the Cry11A inclusions with the other Bt subsp. israelensis toxins; however, deletion of
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the p19 gene had no detectable effect on Cry11Aa synthesis. Therefore, the role of the 19 kDa protein
(orf1) remains unclear [45,46].
The orf3 gene of the cry11A operon encodes a protein of 20 kDa that functions as a molecular
chaperone. When this gene was removed from expression constructs, no Cry11A crystals were
observed in Bt. p20 was effective in enhancing the synthesis of Cry11Aa, as it facilitates the formation
of larger Cry11Aa crystals in acrystalliferous Bt strains and in recombinant Escherichia coli [45,47,48].
The mechanism of Cry11A stabilization by p20 is not known, but it seems to have some functional
role in crystal synthesis in Bt [45,49,50]. This protein may be involved in post-translational processing
(e.g., it may protect the nascent polypeptide from proteolysis by binding with it and allowing crystal
formation) [46]. Moreover, p20 is known to increase the expression levels of other toxins such as
Cyt1Aa, Cry1Ab, Cry1Ac, Cry2A, Cry3A, and truncated Cry1C proteins [34,50–54].
Dervyn et al. [45] suggested that many of the Cry toxin gene configurations that we see today may
have evolved from a common three-gene operon. In some cases, one or both of the non-toxin genes may
have been lost, resulting in monocistronic organization. Loss of orf2 would lead to a situation as seen
with cry10A. For genes such as cry2A [31–33] and cry11A, all of the three genes are still present [45].
4. Toxins with Putative Crystallization Factors
There are many Cry toxin genes found in operons (Figure 3) in which no function has been
ascribed to the other ORFs present. Some examples of these are described below.
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Figure 3. Graphical representation of proteins with putative crystallization factors: (A) Cry6A from Bt
strain YBT-151; (B) Cry9Ca from Bt subsp. Jegathesan; (C) Cry9Ec from Bt serovar galleriae; (D) Cry8Ea
from Bt strain, Bt185; (E) Cry18Aa from Paenibacillus popilliae.
4.1. Cry6A
Cry6A crystals, which are toxic against root-knot nematodes, are rice-shaped and produced by Bt
strain YBT-151 [55]. The strain inhibits growth, reduces brood size, and decreases mobility and feeding
of parasitic nematodes [56]. Yu et al. [57] cloned and characterized the cry6A operon containing a
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structural gene (orf1) that encodes 54 kDa toxin having nematicidal activity, a regulatory sequence
(stem-loop), and a regulatory gene (orf2) encoding 45 kDa (Figure 3). Unlike other Cry proteins, the
orf2 gene negatively regulates orf1 gene expression and shares no homology with any known sequence.
The regulatory sequence acts as a cis-factor and results in low level orf2 expression. High level of cry6A
expression is due to involvement of two regulatory factors, a stem-loop and orf2 [57]. It is possible that
high levels of expression facilitate crystallization in the absence of any structural role for these ORFs.
4.2. Cry9Ca
Cry9Ca is toxic against the important lepidopteran pest, Ostrinia nubilalis, as well as secondary
pest insects such as armyworms and cutworms. The cry9Ca operon consists of two orfs, the cry9Ca
toxin gene and an additional orf (Figure 3). The 129.8 kDa toxin is encoded by a second orf of the
operon. The 7 kDa protein product of orf1 shows sequence similarity with ORF1 protein of the cry2Ac
operon. In analogy with the findings of Wu et al. [32], it seems unlikely that this ORF would play an
important role in the expression of the Cry9Ca1 crystal [58].
4.3. Cry9Ec
The Cry9Ec toxin consists of 1154 amino acids with high toxicity against Plutella xylostella [59].
Upstream from the toxin gene a separate orf and a putative promoter region were located, forming
a deduced operon (Figure 3). Analysis of the upstream sequence identified a putative promoter
region that was homologous to that of the cry2A gene recognized by the sporulation-specific Sigma E
factor [60]. It is well known that insertion sequence elements are often located in the vicinity of cry
genes [61]. However, no insertion sequence elements were found adjacent to the cry9Ec1 gene. The orf1
gene was identical to various orfs in Bt operons [32,58]. The putative 19.2 kDa protein encoded by
the orf1 gene was not observed in parasporal inclusions of the Cry9Ec-expressing strain 92-KU-149-8.
Thus, it seems unlikely that ORF1 plays an important role in the production of the Cry9Ec protein [59].
4.4. Cry8Ea
The Cry8Ea toxin specifically shows activity against larvae of the Asian cockchafer
(Holotrichia parallela) [62]. Cry8Ea can be isolated as a 130 kDa protein from spherical inclusions
found in Bt strain BT185 [63]. The gene encoding Cry8Ea exists in an operon with an upstream gene
orf1 (Figure 3). In this operon, orf1 is located 286 bp upstream of cry8Ea. An interesting fact is that two
promoters initiate transcription of the cry8Ea gene. One promoter, Porf1, is present in the upstream
region of the orf1 gene and controlled by the SigE factor. The other, Pcry8E, is found in the intergenic
region between orf1 and cry8Ea and is controlled by the SigH factor [31,33,45,64]. This is a case in which
orf1 and cry8Ea1 form an operon and the cry gene can be transcribed either as a bicistronic message or
as a monocistronic one [65]. As mentioned above, DNA has been proposed as an important component
of crystals which specifically interacts with the protoxin [12,39]. Guo et al. [41] found that DNA and
Cry8Ea form a compact complex. DNA is proposed to help in protecting the protein from aggregation
and also to enhance the tendency of the toxin to move towards the phospholipid membrane [41]. It has
been reported that DNA is degraded by DNases in the midgut of the insect, which is followed by
the release of activated toxin and binding with receptors on the apical microvilli of the insect midgut
cells [66].
4.5. Cry18Aa
Cry18Aa is a 79 kDa protein found in the sporangia of a strain of Paenibacillus popilliae isolated from
a diseased larva of the common cockchafer. The gene encoding Cry18Aa is found in a two-gene operon.
The first gene encodes a 19.6 kDa ORF1 (Figure 3). The cry18Aa gene is located 76 bp downstream
of orf1 [64]. There is no putative promoter between the orfs. The orf1 gene is similar to orf1 of the
cry2Aa [31] and cry2Ac [32] operons, to p19 of the cry11A [45] operon, and to the first orf of the
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cry9Ca [58] operon. When sequence upstream of orf1 was removed, Bt cells did not produce Cry18A,
but the removal of orf1 itself from the operon had no effect [64].
5. No Known Crystallization Factors
There are some 65 kDa-type Cry toxins, such as Cry3A and Cry1I, with no known crystallization
factors. These are described below.
5.1. Cry3A
Cry3A is an example of a cry gene in which high expression levels and crystallization are achieved
without the requirement of any known crystallization factor. The Cry3 toxins (i.e., Cry3A, Cry3B,
and Cry3C) are active against insects of the order Coleoptera and have been reported from Bt subsp.
morrisoni, galleriae, tenebrionis, and tolworthi [67–70]. Cry3A proteins are 70 kDa protoxins that are
expressed under the control of σA, a sigma factor active during vegetative growth in the predivisional
cell [6]. It forms rhomboidal crystals after synthesis [71]. These are toxic to coleopteran insects and also
require proteolytic activation. Although there are no known crystallization factors, much is known
about the expression of Cry3 toxins.
5.1.1. Role of Cry3A Domains in Crystallization
The amino acid sequence of Cry3 proteins corresponds to the N-terminal half of the 135 kDa Cry
protoxins, in essence making these naturally truncated versions of the latter. As these proteins have
no C-terminal crystallization domains characteristic of Cry1 toxins [4], other domains may facilitate
Cry3A crystallization. Domain substitution and mutagenesis suggested that the specific structure of a
conserved block, which spans the junction between domains I and II, was important for the relative
stability of Cry3A and its subsequent crystallization. However, residues of Cry3A other than in helix
α7 must also be involved in crystallization, although they remain to be identified [72].
5.1.2. STAB-SD Sequence
Synthesis of cry3 involves additional transcript stabilization during translation. Studies revealed
that the so-called STAB-SD sequence was found downstream of the 5′ end of the major cry3A
transcript (T-129) and played an important role in stabilizing the Cry3A transcript, assisting net
protein production [4,73]. The function of this sequence is to stabilize mRNA by preventing 5′
to 3′ exoribonuclease degradation, and hence is not directly involved in translation initiation [5].
Mathy et al. [74] reported the role of RNase J1 in the exoribonuclease degradation of the−558 transcript
of cry3A mRNA in the 5′ to 3′ direction. The interaction of 30S ribosomal subunit with STAB-SD
sequence blocks the activity of RNase J1 [74].
5.2. Cry1I
Tailor et al. [75] reported that CryV, subsequently re-named Cry1Ia [71], is toxic to larvae of both
Lepidoptera and Coleoptera. The cry1Ia gene cloned from Bt subsp. kurstaki DSIR732 produces a
protein of 719 amino acids. In Bt strains, this class of toxin gene appeared silent. However in E. coli, the
gene can be heterologously expressed and produces an 81 kDa protein that is biologically active [76].
Masson et al. [77] observed that the encoded Cry1I protein did not accumulate in crystals in Bt
strain HD-133 [78,79]. The Cry1I protein therefore could not be found in the bacterial cell after the T5
sporulation stage [80,81]. This gene was found approximately 500 bp downstream of a cry1A gene.
No upstream promoter-like sequence could be found [76,81,82]. Nevertheless, identified transcripts
showed transcription of cry1I mRNA, but the absence of protein product suggested that translation
was impaired in some way in Bt [77].
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6. Conclusions
Further research on cry gene organization may give us a better understanding of the structural and
functional basis of crystallization factors in Bt. This has significance in biotechnological applications
involving the production of these biopesticides. Understanding crystallization in Bt provides better
knowledge and important new insights which can result in the expression of heterologous proteins as
biologically active crystal inclusions.
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